Literature DB >> 16928741

Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.

Subhash C Verma1, Bharat G Bajaj, Qiliang Cai, Huaxin Si, Todd Seelhammer, Erle S Robertson.   

Abstract

Latency-associated nuclear antigen (LANA) of KSHV is expressed in all forms of Kaposi's sarcoma-associated herpesvirus (KSHV)-mediated tumors and is important for TR-mediated replication and persistence of the virus. LANA does not exhibit any enzymatic activity by itself but is critical for replication and maintenance of the viral genome. To identify LANA binding proteins, we used a LANA binding sequence 1 DNA affinity column and determined the identities of a number of proteins associated with LANA. One of the identified proteins was uracil DNA glycosylase 2 (UNG2). UNG2 is important for removing uracil residues yielded after either misincorporation of dUTP during replication or deamination of cytosine. The specificity of the 'LANA-UNG2 interaction was confirmed by using a scrambled DNA sequence affinity column. Interaction of LANA and UNG2 was further confirmed by in vitro binding and coimmunoprecipitation assays. Colocalization of these proteins was also detected in primary effusion lymphoma (PEL) cells, as well as in a cotransfected KSHV-negative cell line. UNG2 binds to the carboxyl terminus of LANA and retains its enzymatic activity in the complex. However, no major effect on TR-mediated DNA replication was observed when a UNG2-deficient (UNG(-/-)) cell line was used. Infection of UNG(-/-) and wild-type mouse embryonic fibroblasts with KSHV did not reveal any difference; however, UNG(-/-) cells produced a significantly reduced number of virion particles after induction. Interestingly, depletion of UNG2 in PEL cells with short hairpin RNA reduced the number of viral genome copies and produced infection-deficient virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928741      PMCID: PMC1642147          DOI: 10.1128/JVI.01334-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus.

Authors:  D Dittmer; M Lagunoff; R Renne; K Staskus; A Haase; D Ganem
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

2.  Kaposi's sarcoma and Kaposi's sarcoma associated herpesvirus (human herpesvirus 8): where are we now?

Authors:  Y Chang
Journal:  J Natl Cancer Inst       Date:  1997-12-17       Impact factor: 13.506

3.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.

Authors:  M E Ballestas; P A Chatis; K M Kaye
Journal:  Science       Date:  1999-04-23       Impact factor: 47.728

4.  Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.

Authors:  P Kellam; C Boshoff; D Whitby; S Matthews; R A Weiss; S J Talbot
Journal:  J Hum Virol       Date:  1997 Nov-Dec

5.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sun; S F Lin; L Gradoville; Y Yuan; F Zhu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.

Authors:  A Aiyar; C Tyree; B Sugden
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

7.  Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.

Authors:  O Flore; S Rafii; S Ely; J J O'Leary; E M Hyjek; E Cesarman
Journal:  Nature       Date:  1998-08-06       Impact factor: 49.962

8.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

Authors:  N Dupin; C Fisher; P Kellam; S Ariad; M Tulliez; N Franck; E van Marck; D Salmon; I Gorin; J P Escande; R A Weiss; K Alitalo; C Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

9.  Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.

Authors:  D H Kedes; M Lagunoff; R Renne; D Ganem
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  DNA-dependent protein kinase does not play a role in adaptive survival responses to ionizing radiation.

Authors:  E Odegaard; C R Yang; D A Boothman
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

View more
  21 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  Wuguo Chen; Dirk P Dittmer
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

4.  Absence of the uracil DNA glycosylase of murine gammaherpesvirus 68 impairs replication and delays the establishment of latency in vivo.

Authors:  Nana Minkah; Marc Macaluso; Darby G Oldenburg; Clinton R Paden; Douglas W White; Kevin M McBride; Laurie T Krug
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.

Authors:  Pravinkumar Purushothaman; Suhani Thakker; Subhash C Verma
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

6.  Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt.

Authors:  Dominique Kagele; Cyprian C Rossetto; Margaret T Tarrant; Gregory S Pari
Journal:  Virology       Date:  2012-01-10       Impact factor: 3.616

7.  Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.

Authors:  Pravinkumar Purushothaman; Maria E McDowell; James McGuinness; Ruth Salas; Sharif M Rumjahn; Subhash C Verma
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

8.  H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.

Authors:  Hem Chandra Jha; Santosh Kumar Upadhyay; Mahadesh A J Prasad; Jie Lu; Qiliang Cai; Abhik Saha; Erle S Robertson
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

9.  Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex.

Authors:  Mei-Tzu Su; I-Hua Liu; Chia-Wei Wu; Shu-Ming Chang; Ching-Hwa Tsai; Pei-Wen Yang; Yu-Chia Chuang; Chung-Pei Lee; Mei-Ru Chen
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

10.  Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription.

Authors:  David Fenard; Laurent Houzet; Eric Bernard; Audrey Tupin; Sonia Brun; Marylène Mougel; Christian Devaux; Nathalie Chazal; Laurence Briant
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.